Cargando…
Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
BACKGROUND: The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients...
Autores principales: | Park, Yu Jin, Hong, Duck Jin, Yoon, Eun-Jeong, Kim, Dokyun, Choi, Min Hyuk, Hong, Jun Sung, Lee, Hyukmin, Yong, Dongeun, Jeong, Seok Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056399/ https://www.ncbi.nlm.nih.gov/pubmed/30027698 http://dx.doi.org/10.3343/alm.2018.38.6.545 |
Ejemplares similares
-
Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021) -
Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017) -
Two types of colistin heteroresistance in Acinetobacter
baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020) -
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019) -
Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)